Combination Therapy with LXW7 and Ceria Nanoparticles Protects against Acute Cerebral Ischemia/Reperfusion Injury in Rats

Abstract

Ischemia/reperfusion is known to greatly increase oxidative stress in the penumbra, which results in brain damage. Integrin αvβ3 is selectively up-regulated with ischemic injury to the brain and remains elevated throughout reperfusion. We determined whether or not a new compound biotinylated-LXW7-ceria nanoparticle (CeNP) (bLXW7-CeNP) plays a role in brain protection in the rat model of middle cerebral artery occlusion/reperfusion and shows better effects than CeNPs alone in improving the outcomes of focal oxidative stress and apoptosis more effectively. Male Sprague-Dawley rats were subjected to focal cerebral ischemia for 2 h followed by a 24-h reperfusion. Drug treatment was intravenously administered via the caudal vein 1 h after occlusion. Rats were randomly divided into the following 4 groups: bLXW7-CeNP treatment group (0.5 mg/kg); CeNP treatment group (0.5 mg/kg); control saline group; and sham group. Brains were harvested 24 h after reperfusion, and the neurologic deficit scores, infarction volume, blood-brain barrier (BBB) disruption, and the level of oxidative stress and apoptosis were determined. Results showed that the bLXW7-CeNP and CeNP treatments could improve neurologic deficit scores, infarction volume, BBB disruption, and the level of oxidative stress and apoptosis. Compound bLXW7-CeNP treatment exhibited better effects than CeNp treatment and showed remarkable statistical differences in the infarction volume, the degree of BBB breakdown, the apoptosis and oxidative stress, apart from neurologic deficit scores. Thus, we concluded that bLXW7-CeNP protects against acute cerebral ischemia/reperfusion injury. BLXW7, as a ligand of integrin αvβ3, may be able to effectively localize the anti-oxidant CeNPs to the ischemic penumbra region, which may provide more adequate opportunities for CeNPs to exert anti-oxidative stress effects and subsequently reduce apoptosis in acute cerebral ischemia/reperfusion.

Keywords

ceria nanoparticles / integrin αvβ3 / LXW7 / cerebral ischemia / oxidative stress

References

[1] CaplanL HonFK. Clinical diagnosis of patients with cerebrovascular disease. Prim Care, 2004, 31: 95-109

[2] AronowskiJ, StrongR, GrottaJC. Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats. J Cereb Blood Flow Metab, 1997, 17(10): 1048-10 56

[3] MurinR, DrgovaA, KaplanP, et al.. Ischemia/reperfusion-induced oxidative stress causes structural changes of brain membrane proteins and lipids. Gen Physiol Biophys, 2001, 20(4): 431-438

[4] AllenCL, BayraktutanU. Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke, 2009, 4(6): 461-470

[5] ChanPH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab, 2001, 21(1): 2-14

[6] KimCK, KimT, ChoiIY, et al.. Ceria nanoparticles that can protect against ischemic stroke. Angew Chem Int Ed Engl, 2012, 51(44): 11039-11043

[7] QiX, ZhouR, LiuY, et al.. Trans-cinnamaldehyde protected PC12 cells against oxygen and glucose deprivation/reperfusion (OGD/R)-induced injury via anti-apoptosis and anti-oxidative stress. Mol Cell Biochem, 2016, 421(l-2): 67-74

[8] WangCP, ShiYW, TangM, et al.. Isoquercetinameliorates cerebral impairment in focal ischemia through anti-oxidative, anti-inflammatory, and anti-apoptotic effects in primary culture of rat hippocampal neurons and hippocampal CA1 region of rats. Mol Neurobi-ol, 2017, 54(3): 2126-2142

[9] WangB, TianS, WangJ, et al.. Intraperitoneal administration of thioredoxin decreases brain damage from ischemic stroke. Brain Res, 2015, 1615: 89-97

[10] HeckertEG, KarakotiAS, SealS, et al.. The role of cerium redox state in the SOD mimetic activity of nanoceria. Biomaterials, 2008, 29(18): 2705-2709

[11] KorsvikC, PatilS, SealS, et al.. Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem Commun, 2007, 10: 1056-1058

[12] PirmohamedT, DowdingJM, SinghS, et al.. Nanoceria exhibit redox state-dependent catalase mimetic activity. Chem Commun, 2010, 46(16): 2736-2738

[13] SinghS, DosaniT, KarakotiAS, et al.. A phosphate-dependent shift in redox state of cerium oxide nanoparticles and its effects on catalytic properties. Biomaterials, 2011, 32(28): 6745-6753

[14] Antioxidants (Basel), 2016, 5(2):

[15] KwonHJ, ChaMY, KimD, et al.. Mitochondria-targeting ceria nanoparticles as antioxidants for Alzheimer's disease. ACS Nano, 2016, 10(2): 2860-2870

[16] SchubertD, DarguschR, RaitanoJ, et al.. Cerium and yttrium oxide nanoparticles are neuroprotective. Biochem Biophys Res Commun, 2006, 342(1): 86-91

[17] HeckmanKL, DeCoteauW, EstevezA, et al.. Custom cerium oxide nanoparticles protect against a free radical mediated autoimmune degenerative disease in the brain. ACS Nano, 2013, 7(12): 10582-10596

[18] ZhaoG, ZhangW, LiL, et al.. Pinocembrin protects the brain against ischemia-reperfusion injury and reverses the autophagy dysfunction in the penumbra area. Molecules, 2014, 19(10): 15786-15798

[19] BurnettCA, XieJ, QuijanoJ, et al.. Synthesis, in vitro, and in vivo characterization of an integrin alpha( v)beta(3)-targeted molecular probe for optical imaging of tumor. Bioorg Med Chem, 2005, 13(11): 3763-3771

[20] OkadaY, CopelandBR, HamannGF, et al.. Integrin alpha v beta3 is expressed in selected microvessels after focal cerebral ischemia. Am J Pathol, 1996, 149(1): 37-44

[21] AbumiyaT, LuceroJ, HeoJH, et al.. Activated microvessels express vascular endothelial growth factor and integrin alpha(v)beta3 during focal cerebral ischemia. J Cereb Blood Flow Metab, 1999, 19(9): 1038-1050

[22] XiaoW, WangY, LauEY, et al.. The use of onebead one-compound combinatorial library technology to discover high-affinity alpha(v)beta3 integrin and cancer targeting arginine-glycine-aspartic acid ligands with a built-in handle. Mol Cancer Ther, 2010, 9(10): 2714-2723

[23] CulmseeC, JunkerV, WolzP, et al.. Lubeluzole protects hippocampal neurons from excitotoxicity in vitro and reduces brain damage caused by ischemia. Eur J Pharmacol, 1998, 342(2-3): 193-201

[24] FangT, ZhouD, LuL, et al.. LXW7 ameliorates focal cerebral ischemia injury and attenuates inflammatory responses in activated microglia in rats. Braz J Med Biol Res, 2016, 49(9): e5287

[25] LongaEZ, WeinsteinPR, CarlsonS, et al.. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 1989, 20(1): 84-91

[26] CeulemansAG, ZgavcT, KooijmanR, et al.. Mild hypothermia causes differential, time-dependent changes in cytokine expression and gliosis following endothelin-1-induced transient focal cerebral ischemia. J Neuroinflammation, 2011, 8: 60

[27] AshwalS, ToneB, TianHR, et al.. Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfiision. Stroke, 1998, 29(5): 1037-1046

[28] PaxinosG, WatsonC. The rat brain in stereotaxic coor-dinates: hard cover edition, 2006

[29] HanSZ, WangG, LiZY, et al.. The number of microglia in penumbra following focal cerebral ischemia in rats and its significance observed by confocal laser microscopy. Stroke Vase Neurol (Chinese), 2010, 05: 399-403

[30] ChenJ, LiY, WangL, et al.. Therapeutic benefit of in-travenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke, 2001, 32(4): 1005-1011

[31] ThompsonB J, RonaldsonPT. Drug delivery to the is-chemic brain. Adv Pharmacol, 2014, 71: 165-202

[32] LochheadJJ, McCaffreyG, QuigleyCE, et al.. Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. J Cereb Blood Flow Metab, 2010, 30(9): 1625-1636

[33] SchreibeltG, KooijG, ReijerkerkA, et al.. Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J, 2007, 21(13): 3666-3676

[34] FabianRH, DeWittDS, KentTA. In vivo detection of superoxide anion production by the brain using a cytochrome c electrode. J Cereb Blood Flow Metab, 1995, 15(2): 242-247

[35] ZhaoY, PatzerA, HerdegenT, et al.. Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats. FASEB J, 2006, 20(8): 1162-1175

[36] AksenovaMV, AksenovMY, MactutusCF, et al.. Cell culture models of oxidative stress and injury in the central nervous system. Curr Neurovasc Res, 2005, 2(1): 73-89

[37] RakhitR, CunninghamP, Furtos-MateiA, et al.. Oxi dation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J Biol Chem, 2002, 277(49): 47551-47556

[38] Bar-OrD, Bar-OrR, RaelLT, et al.. Oxidative stress in severe acute illness. Redox Biol, 2015, 4: 340-345

[39] SentellasS, Morales-IbanezO, ZanuyM, et al.. GSSG/GSH ratios in cryopreserved rat and human hepatocytes as a biomarker for drug induced oxidative stress. Toxicol In Vitro, 2014, 28(5): 1006-1015

[40] CircuML, AwTY. Glutathione and apoptosis. Free Radic Res, 2008, 42(8): 689-706

[41] JamesSJ, RoseS, MelnykS, et al.. Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism. FASEB J, 2009, 23(8): 2374-2383

[42] ReddyMK, LabhasetwarV. Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury. FASEB J, 2009, 23(5): 1384-1395

[43] ZhengS, BaiYY, LiuY, et al.. Salvaging brain ischemia by increasing neuroprotectant uptake via nanoagonist mediated blood brain barrier permeability enhancement. Biomaterials, 2015, 66: 9-20

[44] PengL, LiuR, MarikJ, et al.. Combinatorial chemistry identifies high-affinity peptidomimetics against alpha4betal integrin for in vivo tumor imaging. Nat Chem Biol, 2006, 2(7): 381-389

[45] LuLQ, FangT, ZhouD, et al.. Efficiency of integrin alphavbeta3 inhibitor Cilengitide in acute cerebral ischemia in rats. Zhonghua Yi Xue Za Zhi (Chinese), 2016, 96(7): 559-564

[46] MesseSR, FonarowGC, SmithEE, et al.. Use of tissue-type plasminogen activator before and after publication of the European Cooperative Acute Stroke Study III in Get With The Guidelines-Stroke. Circ Cardiovasc Qual Outcomes, 2012, 5(3): 321-326

[47] ShahK, AbbruscatoT. The role of blood-brain barrier transporters in pathophysiology and pharmacotherapy of stroke. Curr Pharm Des, 2014, 20(10): 1510-1522